why choose us

First received: March 23, 2023

Clinical Trial: Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.

Study Status: Completed

Recruit Status: RECRUITING

Condition: COVID-19

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase IIa/IIb Study to Evaluate the Safety, Tolerability, and Efficacy of NP-101 in Treating High-Risk Participants Who Have Tested Po

Brief Summary: The goal of this clinical trial is to evaluate the safety, tolerability, and efficacy of NP-101 in treating high-risk participants who have tested positive for Covid-19.The main question[s] it aims to answer are:To evaluate the safety of NP-101, as well as establish the maximum tolerated dose in high risk Covid-19 positive patients.Participants will [describe the main tasks participants will be asked to do, treatments they'll be given and use bullets if it is more than 2 items].If there is a comparison group:…

Read more